Stockreport

Arcturus Therapeutics: Downgrading To "Hold" As CF Program Shifts Population Focus [Seeking Alpha]

Arcturus Therapeutics Holdings Inc.  (ARCT) 
Last arcturus therapeutics holdings inc. earnings: 3/11 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.arcturusrx.com/investor-relations
PDF ARCT-032 will now target the smaller Class I CF subpopulation, with a 12-week phase 2 trial expected to start in H1 2026. ARCT-810 for OTC deficiency remains a key pi [Read more]